U.S. flag

An official website of the United States government

NM_000257.4(MYH7):c.5135G>A (p.Arg1712Gln) AND Cardiomyopathy

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Oct 18, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001170487.17

Allele description [Variation Report for NM_000257.4(MYH7):c.5135G>A (p.Arg1712Gln)]

NM_000257.4(MYH7):c.5135G>A (p.Arg1712Gln)

Genes:
LOC126861897:BRD4-independent group 4 enhancer GRCh37_chr14:23884455-23885654 [Gene]
MYH7:myosin heavy chain 7 [Gene - OMIM - HGNC]
MHRT:myosin heavy chain associated RNA transcript [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
14q11.2
Genomic location:
Preferred name:
NM_000257.4(MYH7):c.5135G>A (p.Arg1712Gln)
Other names:
p.R1712Q:CGG>CAG; NM_000257.3(MYH7):c.5135G>A; NM_000257.4(MYH7):c.5135G>A
HGVS:
  • NC_000014.9:g.23415651C>T
  • NG_007884.1:g.25011G>A
  • NM_000257.4:c.5135G>AMANE SELECT
  • NP_000248.2:p.Arg1712Gln
  • LRG_384t1:c.5135G>A
  • LRG_384:g.25011G>A
  • NC_000014.8:g.23884860C>T
  • NM_000257.2:c.5135G>A
  • NM_000257.3:c.5135G>A
  • NR_126491.1:n.83C>T
  • c.5135G>A
Protein change:
R1712Q
Links:
dbSNP: rs193922390
NCBI 1000 Genomes Browser:
rs193922390
Molecular consequence:
  • NM_000257.4:c.5135G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NR_126491.1:n.83C>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Cardiomyopathy (CMYO)
Synonyms:
Cardiomyopathies
Identifiers:
MONDO: MONDO:0004994; MedGen: C0878544; Human Phenotype Ontology: HP:0001638

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001333068CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Apr 27, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV001352081Color Diagnostics, LLC DBA Color Health
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Oct 18, 2023)
germlineclinical testing

PubMed (18)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

"Anti-emetic" activity of tetrahydrocannabinol in rats and pigeons.

ten Ham M, de Jong Y.

N Engl J Med. 1978 Apr 6;298(14):798-9. No abstract available.

PubMed [citation]
PMID:
564455

Shared genetic causes of cardiac hypertrophy in children and adults.

Morita H, Rehm HL, Menesses A, McDonough B, Roberts AE, Kucherlapati R, Towbin JA, Seidman JG, Seidman CE.

N Engl J Med. 2008 May 1;358(18):1899-908. doi: 10.1056/NEJMoa075463. Epub 2008 Apr 9.

PubMed [citation]
PMID:
18403758
PMCID:
PMC2752150
See all PubMed Citations (18)

Details of each submission

From CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario, SCV001333068.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Color Diagnostics, LLC DBA Color Health, SCV001352081.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (18)

Description

This missense variant replaces arginine with glutamine at codon 1712 in the LMM domain of the MYH7 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in over 30 individuals affected with hypertrophic cardiomyopathy (PMID: 18403758, 21511876, 23785128, 24510615, 27247418, 27532257, 28771489, 30297972, 31308319, 33495596, 33495597, 34352619, 34542152, 35026164, 35176171). It has been shown that this variant segregates with disease in over 20 affected relatives across at least 10 families (PMID: 37488328; ClinVar SCV000564455.5). This variant has been shown to have both age- and sex-dependent penetrance (PMID: 37488328). This variant has been identified in 6/282354 chromosomes in the general population by the Genome Aggregation Database (gnomAD). A different variant affecting the same codon, p.Arg1712Trp, is considered to be disease-causing (Clinvar variation ID: 14118), indicating that arginine at this position is important for MYH7 protein function. Based on the available evidence, this variant is classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 30, 2024